UPDATE 1-Canada says working with U.S. FDA to address EpiPen shortage
April 17, 2018 at 15:44 PM EDT
TORONTO, April 17 (Reuters) - Canada's government health agency said on Tuesday it is working with the U.S. Food and Drug Administration to address a shortage of Mylan N.V.'s EpiPen emergency allergy antidote that has hit several countries outside of the United States, where it is manufactured.